MediWound (MDWD) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on MediWound (MDWD) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.15 of bullish evidence against -0.52 bearish.

MediWound last closed at $12.54, +0.97% on the session.

Against the IVW growth benchmark the position is +0.17% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for MDWD so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks MediWound in the 19th percentile on return on equity, where 100 is best.

MediWound is classified under Health Care / Pharmaceuticals, with a market capitalisation of $160.34M.

StockMap tracks MediWound as the 94th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite MediWound ranks 121st of 151 in the group, against a group median of -0.08.